NopalCyber Expands Legal Industry Engagement with Investments in
Sponsorship of March Virtual Lunch series and exhibiting at Legalweek New York underscore company’s commitment to building its presence and...
Upcoming Investments
U.S. Gains Market Share Amid Ongoing Global Real Estate Contraction
In the United States, the market edged down to $4.9 trillion from $5 trillion in 2023. Despite this decline, the...
Simon Property Group Raises Guidance After Q2 Earnings, Occupancy Gains – Commercial Observer
Simon Property Group is easing off the tariff alarm it sounded earlier this year after posting better-than-expected second quarter numbers....
Carlyle Secures $9 Billion for New U.S. Real Estate Fund Despite Market Challenges, ETRealty
NEW YORK: Carlyle has raised $9 billion for its latest U.S. real estate fund, the investment group told Reuters on...
Congress’s “One Big Beautiful Bill” Will Shrink Renewable Energy Investments—Yet Some Technologies Are Preserved
Carolyn Kissane, academic director and clinical professor at the Center for Global Affairs at New York University, leads the conversation...
Vanguard’s first ‘outsider’ boss looks to innovate
Vanguard Group has added more than $1 trillion in customer assets, from stock-market gains and new investments, since Salim Ramji was named the first...
PAYA Renews and Expands Youth Apprenticeship Investments
The Partnership to Advance Youth Apprenticeship (PAYA) is pleased to announce renewed and expanded investments in high-quality youth apprenticeship programs...
Harrison Sitomer’s 10-Year Rise From Intern to Chief Investment Officer – Commercial Observer
Harrison Sitomer, SL Green Realty’s chief investment officer, grew up on the East Side by Second Avenue, on pre-Billionaires’ Row...
Retirement Investments: A Beginner’s Guide
Advancements in medicine and technology are helping us live longer than ever before. The prospect of living in retirement for...
Skye Bioscience to Participate in Upcoming Investment Conferences
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on...
